Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ABVXATNM

Abivax S.A.

ABVX · $88.01

55Fair

Actinium Pharmaceuticals, Inc.

ATNM · $1.52

78Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ABVX

55/100

ATNM

78/100

Quality

Is it a profitable, well-run business?

ABVX

6.0/10

ATNM

9.5/10

Growth

Is the company growing?

ABVX

5.0/10

ATNM

5.9/10

Valuation

Is the price reasonable? (higher = cheaper)

ABVX

3.3/10

ATNM

8.8/10

Risk

How risky are the shares? (higher = lower risk)

ABVX

4.1/10

ATNM

5.0/10

Momentum

Is the share price trending up?

ABVX

4.6/10

ATNM

8.4/10

Financial strength

Is the balance sheet healthy?

ABVX

6.3/10

ATNM

5.8/10

The balanced view

Model-generated

Abivax S.A.

This company has a mixed profile, with supportive analyst views, although its current valuation deserves attention.

Leads on: financial strength

Best feature: analysts broadly positive (Analyst buy share: 92%)

Watch out: valuation may be demanding (P/E (TTM): -16.7x)

Actinium Pharmaceuticals, Inc.

This company scores well across most areas, with supportive analyst views and strong profitability.

Leads on: quality, growth, valuation, risk, momentum

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: weakest area: risk profile (Price volatility (1Y, annualised): 72%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.